5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the International AIDS Society 2010-11, Vol.13, p.6
Hauptverfasser:	Lazzarin, A, Johnson, M, Ribera, E, Weitner, L, Chen, S.S, Warren, D.R
Format:	Artikel
Sprache:	eng
Schlagworte:	Demographic aspects Dosage and administration Drug therapy Efavirenz Emtricitabine HIV infection Tenofovir Testing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page	6
container_title	Journal of the International AIDS Society
container_volume	13
creator	Lazzarin, A Johnson, M Ribera, E Weitner, L Chen, S.S Warren, D.R
description
doi_str_mv	10.1186/1758-2652-13-S4-P6
format	Article
fullrecord	<record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A723607138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A723607138</galeid><sourcerecordid>A723607138</sourcerecordid><originalsourceid>FETCH-LOGICAL-g668-6b8afb3666eb744fcd42351cdf7b67c0435f5c8a12a39581f97ce678a6cace573</originalsourceid><addsrcrecordid>eNptjkFLw0AQhRdRsFb_gKcFz6vZbHZ2eyxFrVCwYO9lspmJK-kGkiDEX2-KIj14esM3H48nxK3O7rX28KCd9SoHmytt1FuhtnAmZn_w_OS-FFd9_5FlkPtiMRNbq0bCTvbINIwSUyWJOQYMo2xZDu8k2xRIVRib43uIHQ1d-xk7bGRHdTxQOorEODFKX9figrHp6eY352L39LhbrdXm9flltdyoGsArKD1yaQCASlcUHKoiN1aHil0JLmSFsWyDR52jWViveeECgfMI0zKyzszF3U9tjQ3tY-J26DAcYh_2S5cbyJw2frLUP1ZNiab5bSKOEz7xvwF6bGC-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz</title><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Springer Nature OA Free Journals</source><creator>Lazzarin, A ; Johnson, M ; Ribera, E ; Weitner, L ; Chen, S.S ; Warren, D.R</creator><creatorcontrib>Lazzarin, A ; Johnson, M ; Ribera, E ; Weitner, L ; Chen, S.S ; Warren, D.R</creatorcontrib><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.1186/1758-2652-13-S4-P6</identifier><language>eng</language><publisher>John Wiley & Sons, Inc</publisher><subject>Demographic aspects ; Dosage and administration ; Drug therapy ; Efavirenz ; Emtricitabine ; HIV infection ; Tenofovir ; Testing</subject><ispartof>Journal of the International AIDS Society, 2010-11, Vol.13, p.6</ispartof><rights>COPYRIGHT 2010 John Wiley & Sons, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Lazzarin, A</creatorcontrib><creatorcontrib>Johnson, M</creatorcontrib><creatorcontrib>Ribera, E</creatorcontrib><creatorcontrib>Weitner, L</creatorcontrib><creatorcontrib>Chen, S.S</creatorcontrib><creatorcontrib>Warren, D.R</creatorcontrib><title>5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz</title><title>Journal of the International AIDS Society</title><subject>Demographic aspects</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Efavirenz</subject><subject>Emtricitabine</subject><subject>HIV infection</subject><subject>Tenofovir</subject><subject>Testing</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjkFLw0AQhRdRsFb_gKcFz6vZbHZ2eyxFrVCwYO9lspmJK-kGkiDEX2-KIj14esM3H48nxK3O7rX28KCd9SoHmytt1FuhtnAmZn_w_OS-FFd9_5FlkPtiMRNbq0bCTvbINIwSUyWJOQYMo2xZDu8k2xRIVRib43uIHQ1d-xk7bGRHdTxQOorEODFKX9figrHp6eY352L39LhbrdXm9flltdyoGsArKD1yaQCASlcUHKoiN1aHil0JLmSFsWyDR52jWViveeECgfMI0zKyzszF3U9tjQ3tY-J26DAcYh_2S5cbyJw2frLUP1ZNiab5bSKOEz7xvwF6bGC-</recordid><startdate>20101101</startdate><enddate>20101101</enddate><creator>Lazzarin, A</creator><creator>Johnson, M</creator><creator>Ribera, E</creator><creator>Weitner, L</creator><creator>Chen, S.S</creator><creator>Warren, D.R</creator><general>John Wiley & Sons, Inc</general><scope/></search><sort><creationdate>20101101</creationdate><title>5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz</title><author>Lazzarin, A ; Johnson, M ; Ribera, E ; Weitner, L ; Chen, S.S ; Warren, D.R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g668-6b8afb3666eb744fcd42351cdf7b67c0435f5c8a12a39581f97ce678a6cace573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Demographic aspects</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Efavirenz</topic><topic>Emtricitabine</topic><topic>HIV infection</topic><topic>Tenofovir</topic><topic>Testing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lazzarin, A</creatorcontrib><creatorcontrib>Johnson, M</creatorcontrib><creatorcontrib>Ribera, E</creatorcontrib><creatorcontrib>Weitner, L</creatorcontrib><creatorcontrib>Chen, S.S</creatorcontrib><creatorcontrib>Warren, D.R</creatorcontrib><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lazzarin, A</au><au>Johnson, M</au><au>Ribera, E</au><au>Weitner, L</au><au>Chen, S.S</au><au>Warren, D.R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz</atitle><jtitle>Journal of the International AIDS Society</jtitle><date>2010-11-01</date><risdate>2010</risdate><volume>13</volume><spage>6</spage><pages>6-</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><pub>John Wiley & Sons, Inc</pub><doi>10.1186/1758-2652-13-S4-P6</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 1758-2652
ispartof	Journal of the International AIDS Society, 2010-11, Vol.13, p.6
issn	1758-2652 1758-2652
language	eng
recordid	cdi_gale_infotracmisc_A723607138
source	Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Springer Nature OA Free Journals
subjects	Demographic aspects Dosage and administration Drug therapy Efavirenz Emtricitabine HIV infection Tenofovir Testing
title	5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T09%3A12%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5-year%20safety%20and%20efficacy%20of%20the%20once-daily%20antiretroviral%20regimen%20of%20efavirenz&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Lazzarin,%20A&rft.date=2010-11-01&rft.volume=13&rft.spage=6&rft.pages=6-&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.1186/1758-2652-13-S4-P6&rft_dat=%3Cgale%3EA723607138%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A723607138&rfr_iscdi=true